Dr. Carlene MacMillan
MD, FCTMSS, DFAACAP
Co-founder & Chief Product Officer
.webp)
Dr. Carlene MacMillan is a dual board-certified child, adolescent, and adult psychiatrist who serves as Radial’s Chief Product Officer. She focuses on building robust technology infrastructure and advocating for improved insurance coverage to expand access to breakthrough psychiatric treatments.
Background & Experience
Dr. MacMillan previously served as Chief Medical Officer at Osmind, an electronic health record company, and currently advises multiple healthtech and medical device companies.
She earned both her undergraduate and medical degrees from Harvard University, followed by residency and fellowship training at Harvard’s MGH/McLean Hospital.
Available for appointments in
California, Colorado, Connecticut, Florida (Telehealth Only), Illinois, Maryland, Massachusetts, Michigan, Mississippi, New Jersey, New York, Ohio, Texas, Utah, Virginia
Leadership & Professional Service
Dr. MacMillan holds several prominent leadership positions in the psychiatric community.
She actively contributes to the advancement of interventional psychiatry through participation in prospective and post-marketing research for transcranial magnetic stimulation, esketamine and other novel interventions.
Clinical TMS Society
Member-at-Large on the Executive Committee and Co-Chair of the Insurance Committee
Foundation for the Advancement of Clinical TMS
Board Member
American Academy of Child and Adolescent Psychiatry
Co-Chair of the Public Resource Committee
Ketamine Taskforce for Access to Safe Care and Insurance Coverage
Vice President and Board Member
Clinical Expertise & Training
Beyond her work in interventional psychiatry, Dr. MacMillan has extensive training in Mentalization Based Treatment, which she applies across individual therapy, group therapy, family therapy, and team/systems settings. She provides supervision and consultation to colleagues at Radial and internationally.
Thought Leadership
As a recognized psychiatric futurist, Dr. MacMillan speaks regularly at prestigious conferences ranging from the American Psychiatric Association to SXSW.
She frequently engages with media on topics spanning psychedelic medicine to healthcare technology innovations, helping shape the future of mental health treatment.Her unique combination of clinical expertise, technology leadership, and advocacy positions her at the forefront of transforming psychiatric care delivery and accessibility.
Interested in joining our team?
